biotech & health insights 🧬 Biotech News Roundup: FDA Approvals, Earnings Winners, Pipeline Progress and Sharp Market Moves Biotech stocks delivered another volatile session as investors reacted to a wave of clinical updates, FDA decisions, and quarterly earnings reports. Replimune secured a landmark FDA approval, while Insmed and Iovance posted standout commercial quarters that fueled major rallies. Meanwhile, disappointing market…

This content is for subscribers only. Please click here to see our plans.